• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Chromatin Mechanisms Driving Cancer.染色质机制驱动癌症。
Cold Spring Harb Perspect Biol. 2022 Mar 1;14(3):a040956. doi: 10.1101/cshperspect.a040956.
2
Altered primary chromatin structures and their implications in cancer development.改变的初级染色质结构及其在癌症发展中的意义。
Cell Oncol (Dordr). 2016 Jun;39(3):195-210. doi: 10.1007/s13402-016-0276-6. Epub 2016 Mar 23.
3
Epigenetic changes in pediatric solid tumors: promising new targets.儿科实体瘤中的表观遗传学改变:有前途的新靶点。
Clin Cancer Res. 2012 May 15;18(10):2768-79. doi: 10.1158/1078-0432.CCR-11-1921.
4
Core regulatory circuitries in defining cancer cell identity across the malignant spectrum.核心调控回路在恶性肿瘤谱中定义癌细胞特性。
Open Biol. 2020 Jul;10(7):200121. doi: 10.1098/rsob.200121. Epub 2020 Jul 8.
5
Epigenomics in stress tolerance of plants under the climate change.植物在气候变化下的应激耐受中的表观基因组学。
Mol Biol Rep. 2023 Jul;50(7):6201-6216. doi: 10.1007/s11033-023-08539-6. Epub 2023 Jun 9.
6
Mutated Chromatin Regulatory Factors as Tumor Drivers in Cancer.突变的染色质调控因子作为癌症中的肿瘤驱动因素
Cancer Res. 2017 Jan 15;77(2):227-233. doi: 10.1158/0008-5472.CAN-16-2301. Epub 2017 Jan 6.
7
Targeting Chromatin Remodeling for Cancer Therapy.靶向染色质重塑治疗癌症。
Curr Mol Pharmacol. 2019;12(3):215-229. doi: 10.2174/1874467212666190215112915.
8
Epigenetic Determinants of Cancer.癌症的表观遗传决定因素
Cold Spring Harb Perspect Biol. 2016 Sep 1;8(9):a019505. doi: 10.1101/cshperspect.a019505.
9
Chromatin accessibility contributes to simultaneous mutations of cancer genes.染色质可及性促成癌症基因的同时突变。
Sci Rep. 2016 Oct 20;6:35270. doi: 10.1038/srep35270.
10
Targeting chromatin defects in selected solid tumors based on oncogene addiction, synthetic lethality and epigenetic antagonism.基于癌基因成瘾、合成致死和表观遗传拮抗作用,针对选定的实体瘤中的染色质缺陷。
Ann Oncol. 2017 Feb 1;28(2):254-269. doi: 10.1093/annonc/mdw552.

引用本文的文献

1
Pathogenomic fingerprinting to identify associations between tumor morphology and epigenetic states.通过病原体基因组指纹识别肿瘤形态与表观遗传状态之间的关联。
Eur J Cancer. 2025 May 15;221:115429. doi: 10.1016/j.ejca.2025.115429. Epub 2025 Apr 14.
2
Molecular principles underlying aggressive cancers.侵袭性癌症的分子原理。
Signal Transduct Target Ther. 2025 Feb 17;10(1):42. doi: 10.1038/s41392-025-02129-7.
3
The three-dimensional genome drives the evolution of asymmetric gene duplicates via enhancer capture-divergence.三维基因组通过增强子捕获-分化驱动不对称基因重复的进化。
Sci Adv. 2024 Dec 20;10(51):eadn6625. doi: 10.1126/sciadv.adn6625. Epub 2024 Dec 18.
4
Small-molecule disruption of androgen receptor-dependent chromatin clusters.小分子破坏雄激素受体依赖性染色质簇。
Proc Natl Acad Sci U S A. 2024 Nov 26;121(48):e2406239121. doi: 10.1073/pnas.2406239121. Epub 2024 Nov 19.
5
Entinostat as a combinatorial therapeutic for rhabdomyosarcoma.恩替诺特作为横纹肌肉瘤的联合治疗药物。
Sci Rep. 2024 Aug 15;14(1):18936. doi: 10.1038/s41598-024-66545-5.
6
Editorial: Cancer genetics and epigenetics: theranostic targets and mechanisms.社论:癌症遗传学与表观遗传学:诊疗靶点与机制
Front Genet. 2024 Jul 26;15:1446474. doi: 10.3389/fgene.2024.1446474. eCollection 2024.
7
VRK1 Regulates Sensitivity to Oxidative Stress by Altering Histone Epigenetic Modifications and the Nuclear Phosphoproteome in Tumor Cells.VRK1 通过改变肿瘤细胞中的组蛋白表观遗传修饰和核磷蛋白组来调节对氧化应激的敏感性。
Int J Mol Sci. 2024 Apr 30;25(9):4874. doi: 10.3390/ijms25094874.
8
Lineage specific transcription factor waves reprogram neuroblastoma from self-renewal to differentiation.谱系特异性转录因子波将神经母细胞瘤从自我更新重编程为分化。
Nat Commun. 2024 Apr 23;15(1):3432. doi: 10.1038/s41467-024-47166-y.
9
BET Bromodomain Degradation Disrupts Function but Not 3D Formation of RNA Pol2 Clusters.BET溴结构域降解破坏RNA聚合酶2簇的功能但不影响其三维形成。
Pharmaceuticals (Basel). 2023 Jan 29;16(2):199. doi: 10.3390/ph16020199.
10
Chromatin complex dependencies reveal targeting opportunities in leukemia.染色质复合物依赖性揭示白血病的靶向治疗机会。
Nat Commun. 2023 Jan 27;14(1):448. doi: 10.1038/s41467-023-36150-7.

本文引用的文献

1
Predicting master transcription factors from pan-cancer expression data.从泛癌表达数据中预测主转录因子。
Sci Adv. 2021 Nov 26;7(48):eabf6123. doi: 10.1126/sciadv.abf6123. Epub 2021 Nov 24.
2
Hard wiring of normal tissue-specific chromosome-wide gene expression levels is an additional factor driving cancer type-specific aneuploidies.正常组织特异性全染色体基因表达水平的硬连线是驱动癌症类型特异性非整倍体的另一个因素。
Genome Med. 2021 May 25;13(1):93. doi: 10.1186/s13073-021-00905-y.
3
Solid tumours hijack the histone variant network.实体瘤劫持组蛋白变体网络。
Nat Rev Cancer. 2021 Apr;21(4):257-275. doi: 10.1038/s41568-020-00330-0. Epub 2021 Feb 10.
4
Enhancer hijacking determines extrachromosomal circular MYCN amplicon architecture in neuroblastoma.增强子劫持决定神经母细胞瘤中额外染色体环状 MYCN 扩增子的结构。
Nat Commun. 2020 Nov 16;11(1):5823. doi: 10.1038/s41467-020-19452-y.
5
A Structural Model of the Endogenous Human BAF Complex Informs Disease Mechanisms.内源人源 BAF 复合物的结构模型为疾病机制提供了信息。
Cell. 2020 Oct 29;183(3):802-817.e24. doi: 10.1016/j.cell.2020.09.051. Epub 2020 Oct 13.
6
Mammalian SWI/SNF Chromatin Remodeling Complexes: Emerging Mechanisms and Therapeutic Strategies.哺乳动物 SWI/SNF 染色质重塑复合物:新兴机制和治疗策略。
Trends Genet. 2020 Dec;36(12):936-950. doi: 10.1016/j.tig.2020.07.011. Epub 2020 Aug 29.
7
Large-Scale Topological Changes Restrain Malignant Progression in Colorectal Cancer.大规模拓扑变化抑制结直肠癌的恶性进展。
Cell. 2020 Sep 17;182(6):1474-1489.e23. doi: 10.1016/j.cell.2020.07.030. Epub 2020 Aug 24.
8
ARID1A loss in neuroblastoma promotes the adrenergic-to-mesenchymal transition by regulating enhancer-mediated gene expression.神经母细胞瘤中ARID1A缺失通过调节增强子介导的基因表达促进肾上腺素能向间充质转变。
Sci Adv. 2020 Jul 15;6(29):eaaz3440. doi: 10.1126/sciadv.aaz3440. eCollection 2020 Jul.
9
Extrachromosomal DNA is associated with oncogene amplification and poor outcome across multiple cancers.染色体外 DNA 与多种癌症中的癌基因扩增和不良预后相关。
Nat Genet. 2020 Sep;52(9):891-897. doi: 10.1038/s41588-020-0678-2. Epub 2020 Aug 17.
10
Primary Role of the Nucleosome.核小体的主要作用。
Mol Cell. 2020 Aug 6;79(3):371-375. doi: 10.1016/j.molcel.2020.07.020.

染色质机制驱动癌症。

Chromatin Mechanisms Driving Cancer.

机构信息

Department of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, Ohio 44106, USA.

Genetics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20892, USA.

出版信息

Cold Spring Harb Perspect Biol. 2022 Mar 1;14(3):a040956. doi: 10.1101/cshperspect.a040956.

DOI:10.1101/cshperspect.a040956
PMID:34187809
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8886982/
Abstract

The change in cell state from normal to malignant is driven fundamentally by oncogenic mutations in cooperation with epigenetic alterations of chromatin. These alterations in chromatin can be a consequence of environmental stressors or germline and/or somatic mutations that directly alter the structure of chromatin machinery proteins, their levels, or their regulatory function. These changes can result in an inability of the cell to differentiate along a predefined lineage path, or drive a hyperactive, highly proliferative state with addiction to high levels of transcriptional output. We discuss how these genetic alterations hijack the chromatin machinery for the oncogenic process to reveal unique vulnerabilities and novel targets for cancer therapy.

摘要

细胞状态从正常向恶性的转变从根本上是由致癌基因突变与染色质的表观遗传改变共同驱动的。这些染色质的改变可能是环境胁迫或种系和/或体细胞突变的结果,这些突变直接改变染色质机器蛋白的结构、它们的水平或它们的调节功能。这些变化可能导致细胞无法沿着预定的谱系路径分化,或者驱动一种过度活跃、高度增殖的状态,对高水平的转录输出产生依赖。我们讨论了这些遗传改变如何劫持染色质机器来实现致癌过程,从而揭示癌症治疗的独特弱点和新靶点。